Paxil: Anti-depressant (SSRI) causes pulmonary hypertension in newborns
A Canadian study conducted recently has revealed that the anti-depressant Paxil are increasing the risk of having high blood pressure by 80 percent in pregnant women who take Paxil during their pregnancy and increases the risk of pulmonary hypertension in newborns.
Previous studies had demonstrated that pregnant women who take anti-depressant increases the chances of high blood pressure by 50 per cent, 60 per cent with selective serotonin reuptake inhibitor (SSRI).
The recent study indicated that Paxil users encounter 80 per cent risk to have high blood pressure.
FDA approved Paxil in the year 1192. Since then, GlaxoSmithKline produced them and met several lawsuit regarding its side effects and it provided funds to settle the cases.
In the year 2004, FDA required more stringent product warnings and resulted in ‘black box’ Paxil warning.
In the year 2005, FDA issued an alert about the risk of birth defects from Paxil and several studies indicated the induced heart trouble by Paxil when used in early pregnancy.
There were several complaints from the users for pulmonary hypertension in newborns with Paxil when used by mothers during pregnancy
The study reports about Paxil were published in the recent journal of British Journal of Clinical Pharmacology.